Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Sleep Disorders

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1605106

This article is part of the Research TopicThe Advance on Sleep Disorder: Mechanisms and InterventionsView all 6 articles

CPAP Modulation of Sleep Microstructure (N2-SSD and REM-AHI) as Predictors of Neurological Recovery in Ischemic Stroke Patients with Moderate-to-Severe OSA

Provisionally accepted
Tianyu  JingTianyu Jing1,2,3Li-Wen  XuLi-Wen Xu1,2Wenyi  YuWenyi Yu1,2Shutong  SunShutong Sun1,2Yixi  ZhengYixi Zheng1,2Gang  XuGang Xu1,2Xinhao  ShenXinhao Shen1Cheng  ChuCheng Chu1,2*Tieyu  TangTieyu Tang1,2*
  • 1Neurology Department, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu Province, China
  • 2Yangzhou University, Yangzhou, Jiangsu Province, China
  • 3Jiangyin Third People's Hospital, Wuxi, Jiangsu, China

The final, formatted version of the article will be published soon.

Background: There is a disease spectrum of ischemic stroke and obstructive sleep apnea, which are often comorbid in the same patient and consequently increases prognostic risk. CPAP therapy is the primary treatment for stroke-related OSA; however, its positive effects on patient prognosis and the underlying mechanisms remain controversial. Objective: This study aimed to investigate the impact of CPAP therapy on the recovery of IS patients with moderate-to-severe OSA and to identify biomarkers significantly associated with prognosis to assess their predictive value for short-term neurological outcomes. Methods: A total of 141 patients with IS combined with moderate-to-severe OSA admitted to the Affiliated Hospital of Yangzhou University were enrolled. Patients were divided into a CPAP group (n=68) and a control group (n=73). Both groups received systematic treatment and were followed up until 1 month after the onset of stroke symptoms. The CPAP group initiated therapy within 48 hours of stroke onset for 14 days. Baseline data, sleep and stroke-related questionnaires, polysomnography parameters, and sleep spindle characteristics were collected. Neurological functional outcomes were reassessed at the end of the follow-up period, and differences between the two groups were analyzed. Prognostic factors were identified using Spearman correlation analysis and ordered logistic regression.Results: Compared with those in the control group, patients in the CPAP group had lower mRS and NIHSS scores after treatment (p < 0.05), while the BI did not significantly differ. Spearman correlation analysis revealed that mRS scores were positively correlated with the AHI, the AHI during the rapid eye movement stage and the AHI during the non-rapid eye movement stage (all p < 0.05) and negatively correlated with N2-SSD, N3 sleep percentage, and the Mean SpO2 (all p < 0.05). Logistic regression revealed that N2-SSD, Mean SpO2, and REM-AHI were significant predictors of mRS scores. Conclusion: CPAP therapy enhances sleep microstructure and oxygenation parameters, which improves sleep quality. N2-SSD, REM-AHI, and Mean SpO2 are mechanistically linked to functional prognosis and CPAP exerts therapeutic effects through the modulation of these biomarkers. Early CPAP intervention targeting REM-AHI and N2-SSD demonstrates prognostic benefits, which suggests that sleep microstructure-specific metrics may serve as precision therapeutic targets.

Keywords: Continuous Positive Airway Pressure, Sleep Spindles, ischemic stroke, REM-AHI, obstructive sleep apnea

Received: 02 Apr 2025; Accepted: 06 Aug 2025.

Copyright: © 2025 Jing, Xu, Yu, Sun, Zheng, Xu, Shen, Chu and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Cheng Chu, Neurology Department, Affiliated Hospital of Yangzhou University, Yangzhou, 225001, Jiangsu Province, China
Tieyu Tang, Neurology Department, Affiliated Hospital of Yangzhou University, Yangzhou, 225001, Jiangsu Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.